Skan
SKAN Group AG is a Swiss pharmaceutical technology enterprise headquartered in Allschwil, Switzerland. The company is a global leader in the design, development, and manufacture of aseptic isolators, cleanroom containment equipment, and hydrogen peroxide decontamination systems utilized in sterile drug manufacturing, biotechnology research, and hospital pharmacies. Principal revenue is derived through wholesale manufacturing sales of isolator systems and specialized sterilization equipment to global pharmaceutical corporations. SKAN Group AG is publicly listed on the SIX Swiss Exchange.
2 of the funds FundTelligence covers report a position in Skan.
- Sector
- Industrials
- Country
- Switzerland
- Funds holding it
- 2
Funds holding Skan
- DNB Global Enhanced Small Cap — DNB · 0.03 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)